Suchergebnisse - %22Dexamethasone%22

PubPharm (10.026)

1

Subsequent therapy and outcomes in patients with newly diagnosed multiple myeloma experiencing disease progression after quadruplet combinations

enthalten in: British journal of haematology | 2024

von Ravi, G. | Bal, S. | Joiner, L. | +5

2

A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia : A Phase 3 Trial Investigating Blinatumomab (NSC# 765986) in Combination With Chemotherapy in Patients With Newly Diagnosed Standard Risk or Down Syndrome B-Lymphoblastic Leukemia (B-ALL) and the Treatment of Patients With Localized B-Lymphoblastic Lymphoma (B-LLy)

enthalten in: ClinicalTrials.gov | 2024

3

TAP Block With Methyl-prednisolone as a Pain Treatment Modality After Total Abdominal Hysterectomy Procedures : TAP Block With Dexamethasone Versus TAP Block With Methyl-prednisolone as a Pain Treatment Modality After Total Abdominal Hysterectomy Procedures: Randomized Controlled Trial

enthalten in: ClinicalTrials.gov | 2024

4

Is a low dose of dexamethasone sufficient to prevent paclitaxel-related hypersensitivity reactions? A retrospective study in patients with gynecologic malignancy

enthalten in: Expert review of clinical pharmacology | 2024

von Xiao, D. | Yang, Z. | Shi, Y. | +2

5

Impact of prior lenalidomide or proteasome inhibitor exposure on the effectiveness of ixazomib-lenalidomide-dexamethasone for relapsed/refractory multiple myeloma : A pooled analysis from the INSURE study

enthalten in: European journal of haematology | 2024

von Lee, H. | Ramasamy, K. | Macro, M. | +10

6

Long-Term Follow-Up Defines the Population That Benefits from Early Interception in a High-Risk Smoldering Multiple Myeloma Clinical Trial Using the Combination of Ixazomib, Lenalidomide, and Dexamethasone

enthalten in: bioRxiv.org | 2024

von Nadeem, O. | Aranha, M. | Redd, R. | +19

7

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy : A Phase 3 Randomized Trial of Inotuzumab Ozogamicin (NSC#: 772518) for Newly Diagnosed High-Risk B-ALL; Risk-Adapted Post-Induction Therapy for High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and Disseminated B-LLy

enthalten in: ClinicalTrials.gov | 2024

8

Selinexor With Alternating Bortezomib or Lenalidomide Plus Dexamethasone in TIE Newly Diagnosed MM Patients : Selinexor With Alternating Bortezomib or Lenalidomide Plus Dexamethasone in Transplant Ineligible Newly Diagnosed Multiple Myeloma Patients (SABLe): An Investigator Sponsored Trial

enthalten in: ClinicalTrials.gov | 2024

9

Preventive effect of fermented whey protein mediated by Lactobacillus gasseri IM13 via the PI3K/AKT/FOXO pathway in muscle atrophy

enthalten in: Journal of dairy science | 2024

von Jang, J. | Joung, J. | Pack, S. | +1

10

Dose-response relationships of intravenous and perineural dexamethasone as adjuvants to peripheral nerve blocks : a systematic review and model-based network meta-analysis

enthalten in: British journal of anaesthesia | 2024

von Zufferey, P. | Chaux, R. | Lachaud, P. | +3

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[1003]